Skip to main content
Premium Trial:

Request an Annual Quote

Seven HGP Investigators Get Third-Year Funding

Premium

BETHESDA, Md.--The National Human Genome Research Institute here announced that seven sequencing projects have been awarded $60.5 million in funding in the third year of the institute's sequencing strategy pilot project. The group aims to deposit 117 million bases into public databases in the next year, raising the amount of human DNA sequence contributed by the federally funded Human Genome Project to over 184 million bases.

Two investigators new to the pilot program are Glenn Evans at the University of Texas South western Medical Center, awarded $5.04 million, and Bruce Roe of the University of Oklahoma, awarded $2 million. Investigators receiving continued funding are Richard Gibbs, Baylor College of Medicine ($8 million); Eric Lander, White head Institute/MIT ($8.2 million); Richard Myers, Stanford University ($3 million); Maynard Olson, University of Washington ($7.5 million); and Robert Waterston, Washington University ($26.8 million). Former grant recipient, the Institute for Genomic Research has withdrawn from the human genome sequencing pilot project after its founder, Craig Venter, announced plans to launch a private company with Perkin Elmer Applied Biosystems, devoted to sequencing the entire human genome within three years.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.